Today: 21 December 2025
Subscribe
Browse Category

Stock Analysis News 25 September 2025 - 4 October 2025

Super Micro Computer (SUPX) 2025: Can the AI‑Server Pure‑Play Keep Its Edge?

Super Micro Computer (SUPX) 2025: Can the AI‑Server Pure‑Play Keep Its Edge?

Review of SUPX Performance in 2025 Financial results Super Micro Computer’s fiscal‑2025 (year ended June 30 2025) marked another year of explosive growth but also revealed some strains. Net sales for the full year jumped to $22 billion—almost triple revenue in FY‑2023. Fourth‑quarter revenue
4 October 2025
 ·  ·  ·  ·  · 
Quantum Rocket or Bubble? RGTI’s Stunning Surge Explained—And How It Stacks Up to IonQ, D‑Wave, and QUBT

Quantum Rocket or Bubble? RGTI’s Stunning Surge Explained—And How It Stacks Up to IonQ, D‑Wave, and QUBT

Key facts (as of Oct 4, 2025) CEO Subodh Kulkarni: “Our industry‑leading chiplet approach to scaling and strong financial position makes us confident in hitting our end‑of‑year technology goals.” GlobeNewswire What Rigetti does—at a glance Rigetti is a full‑stack, superconducting,
4 October 2025
 ·  ·  ·  ·  · 
Quantum Computing Inc (QUBT) Stock Skyrockets on $500M Fundraising and New Tech Debut – Can the Rally Last?

Quantum Computing Inc (QUBT) Soars 24% on $500M Funding & New “Quantum Secure” Tech – Will It Hit $40?

Recent Performance and Financials Quantum Computing Inc (Nasdaq: QUBT) has a multi-billion-dollar market cap (share count ~185M after the placement), driven by the funding and product buzz. On Oct 2 it closed $19.98 (Nasdaq) stoculator.com. Year-to-date through early October 2025
3 October 2025
 ·  ·  ·  ·  · 
Sarepta Therapeutics (SRPT) Surges After FDA Greenlights Duchenne Gene Therapy – Is a Rebound Ahead?

Sarepta Therapeutics (SRPT) Surges After FDA Greenlights Duchenne Gene Therapy – Is a Rebound Ahead?

Stock Performance and Trends Sarepta’s stock is recovering some ground after steep losses. As of Oct 2, 2025, SRPT closed at $19.57, up about 6.8%for the day investing.com. This followed a general uptrend in recent weeks: SRPT is up roughly 16% over the last
2 October 2025
 ·  ·  ·  ·  ·  · 
DTE Energy (NYSE:DTE) Stock Set to Surge? Analysts Highlight Smart-Grid Wins and AI-Driven Demand

DTE Energy (NYSE:DTE) Stock Set to Surge? Analysts Highlight Smart-Grid Wins and AI-Driven Demand

Stock Performance and Analyst Consensus DTE Energy’s stock has been relatively stable and is trading near its annual highs. On Sept. 26, 2025 the stock closed around $139.36 marketbeat.com. According to MarketBeat, that day’s close was up +1.23%. The shares
29 September 2025
 ·  ·  ·  ·  ·  · 
Biotech Bombshell: MoonLake (MLTX) Shares Tumble 85% on Trial News – Is a $108 Price Target Still Real?

Biotech Bombshell: MoonLake (MLTX) Shares Tumble 85% on Trial News – Is a $108 Price Target Still Real?

Sources: Company filings and press releases globenewswire.com stocktitan.net; financial media (Reuters, Investing.com, Stocktwits, Seeking Alpha) reuters.com stocktwits.com investing.com; market data services stocktitan.net tipranks.com. All figures and quotes are from cited reports.
29 September 2025
 ·  ·  ·  ·  ·  · 
Scholar Rock (SRRK) Just Hit a Regulatory Speed Bump—But the Long‑Term Muscle‑Building Story Still Has Legs

Scholar Rock (SRRK) Just Hit a Regulatory Speed Bump—But the Long‑Term Muscle‑Building Story Still Has Legs

Key facts (as of September 26, 2025) What happened this week (Sept. 23–26) Company snapshot & pipeline Scholar Rock is a late‑stage biotech developing apitegromab, a selective antibody that blocks latent myostatin activation to build/maintain skeletal muscle. Pipeline also includes SRK‑181 (anti‑latent TGF‑β1, oncology; Phase 1)
26 September 2025
 ·  ·  ·  · 
RIG Stock Meltdown: Transocean’s $381M Share Sale Rocks the Market—Will 13% Dilution Fix the Debt Problem or Set Up a Rebound?

RIG Stock Meltdown: Transocean’s $381M Share Sale Rocks the Market—Will 13% Dilution Fix the Debt Problem or Set Up a Rebound?

Key facts (Sept. 25–26, 2025) What just happened—and why it mattered Timeline (Sept. 24–26): Strategic aim: Management is steering fresh equity toward debt reduction, specifically highlighting the 8.00% notes due 2027. If all base proceeds went against those notes, annual
26 September 2025
 ·  ·  ·  ·  ·  · 
1 … 50 51 52 53
Go toTop